Topics
Sector
Geography
Subject

Videos Library

Event Videos

MedAffairs Leaders Forum Europe (Autumn)

Zürich, Switzerland - October 23-25, 2018
Presentation

“Value communication during pathway disruption” : The opportunity and challenge of disruptive medicine including CAR-T & Gene Therapy

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research
Availability: FREE
  • Defining pathway disruption
  • Challenges of value measurement
  • Market Access and Real World Evidence solutions to overcome challenges
Speaker

Amanda Pulfer
Managing Director
PH Associates

Presentation

Real World Evidence Opportunities in Medical Affairs

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research
Availability: FREE
  • Areas of opportunity
  • Main hurdles
  • Elegant method to answer new questions with existing data
  • Methodology – bias and confounding
  • Opportunity for strategic partnership
  • Value for money
Speaker

Torkild Stenbock
General Manager
LINK Medical Research, Norway

Presentation

Patient Centricity in Non-Interventional Real-world Evidence Study Programs

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Patient-Centricity & Care
Availability: FREE
  • Existing data sources as unique tools for study program pre-evaluation
  • Unique patient centric methodology to answer new questions
  • Patient centric, active surveillance methodology as a tool for in-depth validation of special medial outcome events
  • Classical non-interventional study approaches to complement the holistic view on the patient
Speaker

Marc Pignot
Director Real World Research Consulting
Kantar Health, Germany

Presentation

Biopharmaceutical Acceleration Model for Product Development & Commercialization

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Clinical
Availability: FREE
  • Outlining how, historically, product development has largely been disengaged from commercialization
  • Exploring how, in the current environment, health system stakeholders demand both clinical and real-world evidence to inform decisions regarding product use and reimbursement
  • Describing and  illustrating with a case study the  benefits of a Biopharmaceutical Acceleration Model approach to product development and commercialization,  involving comprehensive evidence development to meet clinical, regulatory and commercial needs
Speaker

Erwin De Cock
Principal, Real-World & Late Phase
Syneos Health

Presentation

A cigar is just a cigar...or is it?: Turbocharging MSL Communications

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Digital & Technology, Medical Science Liaison
Availability: FREE

Misunderstanding a simple comment—we’ve all been there. It happens because each of us brings our unique biases and baseline understandings to the table and we interpret what we hear through those biases and baselines. You can increase the chances that your message will be understood accurately by, first, understanding where your listener is coming from. This session will share data and insights regarding MSL training and about some of the beliefs and biases of MSLs and the physicians with whom they communicate.

Speaker

Pamela Peters
Szenior Director, Medical Affairs Strategic Solutions
Medscape

Presentation

The value of digital communications in medical affairs – practical and compliance considerations

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Digital & Technology
Availability: FREE
Speaker

Gemma Allen
Senior Digital Communications Lead
Succinct Medical Communications

Presentation

Metrics to meaning: Measuring the success of medical communications in a digital airspace

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Digital & Technology, Capabilities & Effectiveness
Availability: FREE
  • The importance of metrics to demonstrate value and impact of communication programmes
  • From reach and engagement to behavioural metrics
  • Practical approaches to implementing metrics
Speakers

Robert Poole
Director of Scientific Services
Complete HealthVizion

Stephen Allison
Business Development Director
Complete HealthVizion, UK

Presentation

Leveraging Online Discussion Platforms for Optimal Stakeholder Engagement

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement
Availability: FREE
  • Identify the logistical and resource barriers to domestic and global stakeholder engagement
  • Learn about innovative communication solutions that leading organizations are utilizing to overcome these challenges
  • Discuss the use of these solutions in delivering improved engagement outcomes, while remaining regulatory compliant
Speaker

Lance Hill
CEO
Within3